News for hackers. Stuff that matters.
Re:Dustin Moskovitz pours funds into high-risk research by Eridrus on Wednesday December 27, 2017 @10:32PM (#16020113)
Personally I was quite impressed by what I had read about the "drugs for neglected diseases initiative" (DNDi). I recall seeing an interview where they mentioned that trials are much easier conduct when the disease has very serious effects (i.e. death) and the existing treatments were poor since you needed far less statistical power to show that your treatment was better.

I don't know how Sepsis fits into this, but they specifically do trials that drug companies won't.

There are no comments on this comment yet.